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Abstract 
 
 
Production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) are natural 
processes occurring in the brain. However, overproduction of ROS and RNS may occur during 
aging and contribute to neurodegenerative diseases and disorders such as stroke. Phenolic 
compounds constitute a large class of phytochemicals that are widespread in the plant kingdom 
and known to have antioxidant capacities. This study aimed to determine the radical 
scavenging capacity and reducing power, as well as the polyphenolic content in fruits and 
leaves of blueberries and lingonberries growing in Newfoundland. We determined the potential 
neuroprotective effect of extracts against glutamate-mediated excitotoxicity, which is believed to 
contribute to disorders such as stroke and neurodegenerative diseases. We found that extracts of 
fruits and leaves of blueberry and lingonberry plants have high levels of total soluble 
phenolics, anthocyanins, tannins, and flavonoids. Overall, the levels of these compounds were 
significantly higher in the leaves of these plants versus the fruits. Total antioxidant 
capacity, in terms of radical scavenging activity and reducing power, were much higher in the 
leaves of both plants as compared to their fruits. We then tested the effects of the extracts 
against glutamate-mediated excitotoxicity, a pathological process partially involving 
overproduction of ROS and RNS. Brain-derived cortical cell cultures from neonatal rat pups 
were prepared and grown for 9-16 days in vitro. Cells were exposed to glutamate (100 µM) 
for 24 hours. Glutamate-exposed cells displayed morphological alterations such as disrupted 
cell bodies, and increased dark punctae, which is often indicative of condensed nuclei and 
delayed cell death. Glutamate caused a ~23% cell loss after 24 hours as determined by the 
amount of DAPI-positive nuclei. A specific NMDA receptor blocker (AP5) was used to 
determine the contribution of this receptor type to cell damage. While lingonberry fruit 
extract did not provide protection from glutamate toxicity, blueberry fruit extracts were 
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protective. Cultures treated with leaf extracts of lingonberry and blueberry showed no cell loss 
in the presence of glutamate, indicating a strong protective effect of both the leaf extracts. The 
overall greater protective effect of leaf extracts was in correlation with the levels of phenolics 
and antioxidant capacity. Treatment with AP5 (NMDA receptor blocker) gave us positive 
results and the cell death caused by 100 µM glutamate was suppressed, but the trend was not 
clear enough to make any conclusion. Recent studies have analyzed antibody staining against 
alpha-synuclein, a protein involved with Parkinson’s disease, after glutamate exposure. These 
studies helped us raise a set of questions on the various factors leading to increased expression of 
alpha-synuclein and allowed us to get some preliminary data. I have measured levels of lactate 
in the culture media from different conditions which may be indicative of altered cell health. 
Overall, these findings suggest that berries or their components may provide protection to 
the brain from various pathologies such as stroke, trauma and neurodegenerative diseases. This 
protective effect of berry extracts may be due to a decrease in oxidative stress, nitrosative 
stress, or other damaging mechanisms caused by exposure to glutamate. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Nervous System and Brain 
 
 
Vertebrates have a single nervous system which is divided into the central nervous system 
(CNS) and the peripheral nervous system (PNS). The CNS consists of the brain and spinal 
cord (Seeley, Stephens and Tate, 2006) which controls movement, sensation, higher brain 
functions and other homeostatic functions (Amerman, 2010). The brain is one of the most 
complex organs in the body which is protected within a skull. The brain and spinal cord are 
both covered by a set of connective tissue layers called the meninges. The three 
meninges protecting the brain are the dura matter (outermost), arachinoid matter (middle) 
and the pia matter (innermost). There is plasma like fluid in the space between the pia 
matter and the cerebral hemispheres surrounding the brain called the cerebrospinal fluid 
(CSF), which is formed by blood filtration. The spaces in the brain are called the ventricles 
and are filled with the CSF. The CSF has various functions such as making the brain buoyant, 
cushioning the brain, providing nutrients and hormones to the brain and is also involved in 
removal of waste (Campbell et al., 2005). The brain mainly consists of the cerebral hemispheres 
(cerebrum), the diencephalon (thalamus, hypothalamus and epithalamus) and the cerebellum. 
The cerebrum is the largest portion of the brain and the outermost region of this portion is 
called the cerebral cortex, which is further divided into right and left hemispheres (Kandel, 
Schwartz and Jessell, 2000). The two major kinds of cells found in the brain are neurons and 
glial cells. Glial cells are primarily a supportive tissue for the neurons. Brain cells and 
especially neurons require effective antioxidant protection for two main reasons: 
1. They exhibit higher oxygen consumption compared to other tissues (Braughler and Hall, 
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1989) and  
2. Formation of reactive oxygen and nitrogen species can significantly alter their function. 
1.2 Oxidative stress, Reactive Oxygen and Nitrogen Species  
In healthy cells, molecular oxygen is taken up and then gets converted to superoxide radical 
(O2•−) in the mitochondria. This O2•− has two fates in the cells (See Fig 1.1). The first fate is to 
be converted to peroxynitrite radical (ONOO−) in presence of nitric oxide (NO) and the next is 
in presence of a natural antioxidant enzyme, superoxide dismutase (SOD) where hydrogen 
peroxide (H2O2) is formed. Hydrogen peroxide can further be neutralized in the presence of 
different antioxidant enzymes like catalase and glutathione peroxidase (GPx) and produce no 
harm to the cell. But, one possible mechanism converts H2O2 in a series of reactions called 
Fenton’s reaction to produce hydroxyl radical (•OH), which is harmful to cell. Reactive oxygen 
species (ROS) include O2•−, hydroxyl radicals, and non-radical derivatives of oxygen, such as 
H2O2, whereas examples of reactive nitrogen species (RNS) include NO, ONOO− and nitrogen 
dioxide (NO2•) (Halliwell, 2006). These ROS and RNS are formed in the cells as a part of 
normal metabolic processes contributing to regulatory roles in normal functioning of metabolic 
pathways. However, when there are insufficient levels of natural antioxidant enzymes or 
antioxidants in the cells, overproduction of ROS and RNS takes place. Oxidative stress can be 
described as an imbalance between oxidants (ROS and RNS) and antioxidants in the body 
(Simonion and Coyle, 1996). Another way to define oxidative stress is the metabolic state of 
imbalance between the generation of reactive oxygen species (ROS) and their detoxification 
(Heck, 1968). The stress caused by the over production of RNS is called nitrosative stress.  
       Oxidative and nitrosative stresses are natural processes occurring in the body due to injury, 
aging or some abnormal conditions. The brain is very complex and has a very high rate of 
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oxygen consumption, making it susceptible to oxidative stress (Braughler and Hall, 1989). The 
brain is particularly prone to oxidative damage mainly because of high energy demand of 
neuronal cells as compared to other cells ultimately causing mitochondria to produce more ROS 
(Slemmer et al., 2008). Constant exposure of the brain to relatively high levels of ROS and RNS 
is mainly due to a high metabolic rate of oxygen, which is associated with a high rate of O2•− 
leakage from the mitochondrial electron transport chain (Halliwell, 2006). Since mitochondria 
utilize the vast majority of O2 uptake in order to generate adenosine-tri-phosphate, (ATP), it is 
unavoidable to control the production of ROS during respiration (Rhoads et al., 2006). 
Mitochondria is both a potential source and victim of free radicals (Sastre et al., 2003) and 
mitochondrial decay contributes to aging (Atamna et al., 2002; Ames, 2004). Identified 
mutations in mitochondrial DNA have been found to cause neurological dysfunctions (Gao et 
al., 2008). Production of these free radicals in the brain is more common because the brain cells 
do not possess strong antioxidant defense systems needed to prevent the damage caused by 
oxidative stress. Very low levels of catalase activity are present in the brain and other 
antioxidant enzymes, superoxide dismutase and glutathione peroxidase, are also present in 
moderate quantity (Lau et al., 2005). All of these factors together contribute to oxidative 
damage and later results in apoptosis. Apoptosis or programmed cell death is a natural 
mechanism in which damaged cells are eliminated, so as to prevent its spreading to the adjacent 
cells (Kroemer and Dallaporta, 1998; Hoeberichts and Woltering, 2003). Excess apoptosis can 
cause atrophy. Excessive ROS and RNS mediated damage to cellular proteins, DNA, lipids and 
cell membranes in human beings is responsible for aging (Sastre et al., 2000), neurodegenerative 
diseases (Simonion and Coyle, 1996) and diseases such as mutagenesis, cardiovascular diseases 
(Khan and Baseer, 2000), cancer (Kawanishi et.al., 2001), and several other disorders. 
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Fig 1.1 Critical ROS and RNS pathways in mammalian cells Molecular oxygen can 
be transformed into superoxide (O2
•-
) radicals by various enzymes, particularly in 
mitochondria. Superoxide can combine with nitric oxide (NO•) to form peroxynitrite 
(ONOO-), or can be dismutated by superoxide dismutase (SOD) to form hydrogen 
peroxide (H2O2). Hydrogen peroxide can be neutralized by catalase, by glutathione 
peroxidase (GPx), or can be transformed to a hydroxyl radical (•OH) by the Fenton reaction 
(not shown). GR, glutathione reductase; GSH, reduced glutathione; GSSG, oxidized 
glutathione. To combat or overcome the presence of excess reactive species, the level of 
antioxidants in the brain has to be increased (Modified from Slemmer et al., 2008). 
 
 
 
5  
1.3 Brain Aging and Neurodegenerative Diseases  
 
 
Prolonged oxidative stress causes impairment in normal brain function which is known as 
brain aging (Harman, 1955; Harman, 1994; Lau et al., 2005; Harman, 2006). Dr. Denham 
Harman’s free radical theory of aging states a small amount of injury everyday leads to 
aging of the brain, and also suggests that the lifespan of an organism could be increased by 
reducing radical production and increasing radical scavenging (Kehrer and Smith, 1994). 
Brain aging is a major risk factor and eventually leads to neurodegenerative diseases.  
         Neurodegenerative diseases can be a result of various factors such as genetic defects, 
defective proteins, fibre accumulation or prolonged oxidative stress (brain aging) in a 
specific region of the brain. One common feature of most neurodegenerative diseases is 
the aggregation of mis-folded proteins (Lausted et al., 2013). Protein folding or mis-
folding takes places in the endoplasmic reticulum (ER) and is termed ER stress. Some 
neurodegenerative diseases like Alzhiemer’s disease (AD) and Parkinson’s disease (PD) 
involve ER stress (accumulation of mis-folded proteins) and leads to unfolded protein 
response activation (UPR) (Haynes et al., 2004). This UPR tries to normalize the function of 
the cell and activate signaling pathways which cause protein folding. If protein folding is not 
achieved then production of ROS takes place, which ends up in oxidative stress and cell 
death.  A decrease in misfolded proteins in the ER causes a decrease in oxidative stress. 
Different proteins are involved with each disease and these mis-folded proteins are 
believed to cause the progression of the disease (Frost and Diamond, 2009; De Calignon et 
al., 2012; Hardy Jet al., 2012). Some of the common neurodegenerative diseases are AD and 
PD (Gandhi et al., 2012). A plethora of literature is available on the different mechanisms 
and factors of these diseases but a treatment is still not known. 
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1.3.1 Parkinson’s disease and Lewy Body Dementia 
 
 
Neurodegenerative disorders are known to be very debilitating. PD is the second most 
common neurodegenerative disease after AD (Lees et al., 2009),  which is characterized 
by rigidity, tremors, postural instability, slow movements and many other symptoms (Ross 
et al., 2004). Degeneration of dopaminergic neurons in the substantia nigra of the midbrain 
results in PD (Forno, 1996). The second most common form of dementia after AD is 
Dementia with Lewy bodies (DLB) (Zaccai et al., 2005). The symptoms of DLB overlap 
with those of AD, PD and other disorders involving Lewy body formation (Nervi et al., 
2011) but the three most prominent symptoms are recurrent visual hallucinations, 
Parkinsonism, and fluctuating cognition. The common pathological characteristic of both 
PD and DLB are the formation of Lewy Bodies (Lewy, 1912; Tretiakoff, 1919; Okazaki et 
al., 1961; Kosaka et al., 1976). Lewy Bodies are composed of alpha-synuclein and 
ubiquitin (Spillantini et al., 1997). They are usually found in the substantia nigra and locus 
coeruleus of the brain stem in the case of DLB, but they are also found in the limbic system 
and cortical areas of the brain (Collerton et al., 2003; Zupancic et al., 2011; Nakatsuka et 
al., 2013). Pathologically, aggregates of alpha synuclein protein are seen in the Lewy 
bodies in various regions of the brain in PD (Spillantini et al., 1997). Alpha 
synuclein is a 140 amino acid containing soluble protein (Olanow and Brundin, 2013) 
which is located in pre-synaptic terminals (Lee and Trojanowski, 2006). Folding and mis-
folding of this protein causes changes in the cell (Stefani and Dobson, 2003) such as 
accumulation of ROS, and oxidative stress. Both neurodegenerative and neurological diseases 
involve oxidative stress. Two other common neurological disorders which also involve 
oxidative stress are traumatic brain injury (TBI) and stroke. 
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1.4 Traumatic Brain Injury 
 
 
TBI refers to any kind of physical or mechanical damage to the brain. It is one of the major 
causes of mortality and disability worldwide (Jennet, 1996). The patho-physiology of this 
kind of injury is complicated and is said to consist of two phases. The first phase is called 
the primary (mechanical) damage phase and the second is called the secondary (delayed) 
phase. The primary phase occurs at the moment of injury. It includes contusion, 
laceration, diffuse axonal injury and intracranial hemorrhage which take place immediately 
after the injury (Weber, 2012). Post traumatic production of free radicals takes place within 
a few minutes after the mechanical injury. This free radical production plays a major 
role in the secondary phase of TBI (Ohta et al., 2012). The secondary (delayed) damage 
phase includes processes which occur at the time of injury but do not appear clinically for 
days, weeks or months later after the injury. It includes the activation of degrading 
enzymes, swelling, and ischemia (Weber, 2004). One possible reason for the secondary 
injury is an imbalance in calcium homeostasis (Weber, 2004). This leads to excessive 
intracellular calcium levels in the CNS which is again responsible for the release of free 
radical species and causes damage to proteins, lipids, nucleic acids, and cell membranes 
(McIntosh and Sapolsky, 1996). Overall this process ends up causing cell death and 
pathological changes in cells which may progress into other neurodegenerative diseases. 
Lactate is a by-product of glycolysis and is a biochemical indicator of anaerobic metabolism. 
Lactate measurements after different time frames of TBI can give an estimate about the health 
of cells. Apart from neurodegenerative and neurological disorders, there are other conditions 
which eventually result in production of reactive species. One such condition is the presence 
of excess glutamate at receptors, which is termed glutamate excitotoxicity. 
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1.5 Glutamate Excitotoxicity 
 
 
There are various amino acids required by the body. Some are essential and others are 
non- essential. Essential amino acids are the amino acids,  which are not synthesized in the 
body and have to be supplemented through diet. Some of the essential amino acids are 
phenylalanine, threonine, tryptophan, methionine, valine, and lysine (Young, 1994). Non-
essential amino acids are the amino acids which can be synthesized by the body itself 
and they need not be supplemented through diet. Some of the non-essential amino acids are 
alanine, aspargine, glutamine, glutamic acid, serine and tyrosine. Glutamic acid (glutamate) is 
one such non-essential amino acid present in the body (Chen et al., 2009). Glutamate is 
primarily an excitatory neurotransmitter (Yu et al., 2008) and also the most abundant 
neurotransmitter in the CNS, which is necessary for long-term potentiation, learning, 
memory, and other cognitive functions (Chen et al., 2009). Released glutamate interacts 
with three classes of ionotropic glutaminergic receptors namely N-methyl D-aspartate 
(NMDA), 2-amino, 3-(3-hydroxy- 5-methylisoxazol-4-yl) propionate (AMPA) and Kainate 
receptors (Reidel et al., 2003). Glutamate also reacts with metabotropic glutamate receptors 
(mGluRs). Activation of NMDA receptors leads to depolarization which, releases the Mg
2+
 
block in the receptor and allows the transfer of Ca
2+
 ions (Spandou et al., 2007). AMPA 
receptors are co-expressed with NMDA receptors after the release of Ca
2+
 (Chen and Lipton, 
2006). The primary function of NMDA receptors is the permeability of Na
+
 but not Ca
2+
. 
Prolonged activation of the excitatory glutamate receptors, excessive glutamate in the 
synapse or decreased re-uptake of glutamate from synapses leads to the onset of a 
condition which is referred to as excitotoxicity (Lipton et al., 2008; Vincent and Mulle, 
2009; Dong et al., 2009) (See Fig 1.2). In normal conditions, the neurons try to inhibit 
the activity of pumps responsible for toxicity and bring back glutamate levels to a normal 
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physiological concentration (Gottlieb et al., 2003). However, intense exposure to glutamate 
hyper-activates the receptors and increases intracellular Ca
2+
 levels which then undergo a 
cascade of reactions to finally lyse the cell (Mehta et al., 2012). Cell lysis is a major 
contributing factor in various neuro-degenerative diseases and other disorders such as TBI 
and stroke (Mehta et al., 2012). Therefore, the presence of excess glutamate at the receptors 
or decreased reuptake of glutamate results in increased levels of intracellular calcium. This 
excess intracellular calcium could significantly alter the health of cells. 
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Fig 1.2 Glutamate-mediated neurotransmission and excitotoxicity Glutamate is packaged 
into synaptic vesicles by the vesicular glutamate transporter (vGluT), which are then released 
upon depolarization and influx of extracellular Ca
2+
. Glutamate activates ionotropic receptors 
(i.e. AMPA, kainite, and NMDA receptors) on post-synaptic neurons that causes an influx of Na
+
 
and Ca
2+
. Glutamate activates metabotropic receptors (mGluRs), which leads to the production 
of inositol-trisphosphate (IP3) and can cause the release of Ca
2+ 
from internal stores. Glial 
cells typically clear the synapse of glutamate by uptake through an excitatory amino acid 
transporter (EAAT). Glutamate is then converted to Glutamine (Gln) and then shuttled back to 
neurons, which convert Gln back to glutamate. The increases in Na
+ 
and Ca
2+ 
are important for 
normal physiological functions in the brain. However excessive Na
+ 
influx may lead to 
ionic disturbances and cell swelling, while excess Ca
2+ 
influx can trigger several detrimental 
processes in cells including an increase in oxidative and nitrosative stress. 
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1.6 Calcium mediated cell death 
 
Alterations in the regulation of Ca
2+
 are a leading factor for various diseases such as myocardial 
infarction, stroke, AD and other nervous system disorders (Trump and Berezesky, 1995). 
Overproduction of Ca
2+
 or excessive intracellular Ca
2+
, adjuvant generation of free radicals, and 
reduction of cell energy metabolism play a vital role in the pathogenesis of ischemic stroke 
and TBI (Choi, 1988; Meldrum and Garthwaite, 1990; Coyle and Puttfarcken, 1993; Lipton and 
Rosenberg, 1994). Excessive Ca
2+
 leads to activation of different pathways (See Fig 1.3) which can 
cause cell death. Some enzymes like endonucleases, proteases, phospholipase A2, and NO synthase 
are involved in these pathways. Production and activation of calpains affects the cytoskeletal 
structures further damaging the integrity of the cell (Slemmer et al., 2008). Ultimately, this can 
lead to neuronal death. Activation of Ca
2+
-dependent endonucleases can induce DNA cleavage 
that further causes cell death (Trump and Berezesky, 1995; McConkey and Orrenius, 1996; 
Toescu, 1998). Calcium related mitochondrial damage is another pathway of cell destruction 
(Kristián and Siesjö, 1998). Calmodulin and Phospholipase A2 activation involves the 
production of excess free radicals post-injury which causes cell damage (Slemmer et al., 
2008). Other enzymes like caspases are also activated due to increased levels of Ca
2+
. Induction of 
an apoptotic cascade takes place due to caspase activation (Slemmer et al., 2008). Overall, 
excessive intracellular free calcium levels ([Ca
2+
]i) activate various degradative pathways, 
which mostly lead to cell death by reversible or irreversible phases. Reduction of these excessive 
intracellular calcium levels and finally controlling the oxidative stress or cell death might be 
possible with the help of specific glutamate receptor blockers. Additionally, it is well known that 
oxidative stress can be controlled by antioxidants. These antioxidant compounds may reduce the 
intracellular levels of Ca
2+
 and thus protect the cells against damage and dying. 
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Fig 1.3: Summary of the mechanisms of neuronal damage and death caused by elevated [Ca
2+
]i 
after traumatic injury. NO, nitric oxide; ONOO- , peroxynitrite; O2 -·, superoxide (modified from 
Weber, 2004). 
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1.7 Antioxidants 
 
 
To combat or overcome oxidative stress and increased levels of intracellular Ca
2+
, the level 
of antioxidants in the brain needs to be increased. Some antioxidants naturally found in 
our body are glutathione, catalase, and glutathione peroxidase. Glutathione, a tri-peptide 
consisting of glutamate, cysteine, and glycine is highly important for normal functioning of 
cells, scavenging radicals (Bains et al., 1997), maintaining thiol redox state (Schafer et al., 
2001) and reducing sulphur. Reduction of glutathione is said to cause neurodegeneration 
(Schulz et al., 2000). There are many factors involved in the synthesis of GSH. While 
performing in-vitro experiments, mixed cultures are helpful as astroglial cells reduce 
cystine to cysteine and release it to adjacent neurons (Dringen et al., 1999). This provides 
neurons with cysteine, which is a precursor for the synthesis of GSH. Transport of cysteine 
can take place in the presence of an excitatory amino acid transporter (EAAC1). Neurons 
lacking in EAAC1 transporters show a great decrease in cysteine transportation which in 
turn cuts down the production of glutathione (Dringen et al., 1999), a natural antioxidant 
essential to eliminate oxidative stress. There are five types of sodium dependent excitatory 
amino acid transporters (EAATs); (EAAT1, EAAT2, EAAC1 or EAAT3, EAAT4 and 
EAAT5) each with specific functions and locations (Maragakis et al., 2004). A common 
function of most of these transporters is to regulate the extracellular glutamate levels in 
the CNS. Some of these transporters are mostly distributed to astrocytes and others to 
Purkinje cells in the cerebellum, but EAAC1 is widely expressed throughout the nervous 
system in neurons (Maragakis et al., 2004).  
          The reduced glutathione levels leads to oxidative stress which further causes neural 
deficits, age-dependent abnormalities, neurodegeneration, death of cells, and other 
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abnormalities (Andersen et al., 2004). Therefore, reduction of natural antioxidants in the brain 
leads to oxidative stress conditions and further cell death. To overcome and avoid such a 
situation, consumption of antioxidants available in nature might act as an addition for the natural 
antioxidants and prevent cell death.  
 
 
1.7.1 Health and effects of Nutraceuticals  
 
 
The US Department of Health and human services, along with the US Department of 
Agriculture, published in a report named “Healthy People 2010” that every person above the 
age of two years should eat a minimum of two servings of fruit daily (US Department of 
Health and Human Services, 2005). Diet and exercise are two very important factors for a 
better mind and health. Consumption of junk food can reduce the healing effect of the 
brain as well as cause mental decline over the years whereas consumption of healthy food 
and regular exercise increases the ability of the brain to fight against damage, improve 
cognitive abilities, and facilitate synaptic transmission (Gomez et al., 2008;  2011). The term 
nutraceutical was originally defined by Dr. Stephen DeFelice as being daily nutritional 
supplements like food or a part of food, which have beneficial effects in treating or 
preventing disease (Kalra, 2003). There has been an increasing demand for nutraceuticals 
as plant derived supplements are considered to be much safer than synthetic drugs (Raskin 
et al., 2002). Various dietary components affect health in different ways. A healthy diet, which 
consists of omega-3-fatty acids, curcumin or other polyphenolic compounds tends to elevate 
the levels of brain derived neuro-tropic factor (BDNF), which is useful for the brain in 
maintaining neuronal circuitry and managing learning and memory (Gomez et al., 2011). A 
decrease in levels of BDNF leads to various disorders in the brain such as AD, PD and 
Schizophrenia (Gomez et al., 2011). It is a well- established fact that higher intake of a diet 
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containing β-carotene shows positive results in individuals with risk of cancer (Hennekens, 
1986) and coronary heart disease (Poppel et al., 1994). Docosahexaenoic acid, a component 
Omega-3-fatty acid, is very essential for the recovery of damaged neuronal membrane 
(Jones et al., 1997). Polyphenols are another broad class of phytochemicals that are 
widespread in the natural kingdom and are available in berry plants in high concentrations. As 
the name suggests, these polyphenols have multiple phenol groups, and they are powerful 
antioxidants. These phenolic compounds are the secondary metabolites of the plants which 
are derived from phenylalanine and tyrosine (Shahidi and Naczk, 2004; Naczk and Shahidi, 
2006). They are useful for the plant defence system against stress and pathogens (Shahidi and 
Naczk, 2004; Naczk and Shahidi, 2006). Polyphenols have potential beneficial effects such as 
anti-inflammatory, anticancer, antifungal, antimicrobial, and antiulcer properties (Rahman et 
al., 2007). Chronic diseases, such as cardiovascular disease and AD can be improved with 
an intake of phenolic compounds and anthocyanins containing fruits and green leafy 
vegetables (Joshipura et al., 2001; Huxley and Neil, 2003; Castrejón et al., 2008; Krikorian 
et al., 2010). They are widely available in fruits and vegetables (plants) and show beneficial 
effects on the brain. Berry crops are very rich sources of polyphenolic antioxidants, 
particularly flavanoid compounds (Zeng et al., 2003) and can be used in our diet to provide the 
beneficial effects of antioxidants. These berries are considered to be nutraceuticals as they are a 
part of food and have positive health effects. There are various kinds of berry plants and each of 
it has its own beneficial effect based on its chemical profile. 
 
1.8 Berries and Leaves 
Berries are small fleshy fruits which are low in calories but high in moisture. They contain 
both soluble and insoluble fibres (US Department of Agriculture National Nutrition 
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Database). The fruits contain low levels of sodium and large amounts of potassium and 
natural antioxidants, such as vitamins C and E. They are naturally rich in micronutrients: folic 
acid, calcium, selenium, α- and β-carotene, and lutein. Berries have been reported to have 
diverse health promoting phytochemicals and are very rich sources of polyphenolics 
especially flavonoids, phenolic acids, anthocyanins, and proanthocyanidins (Zheng and 
Wang, 2003). An enormous body of research has been published suggesting that the dietary 
consumption of berries has positive effects on human health and diseases (Sreeram, 2008; 
Battino et al., 2009). The health promoting properties of berries are gaining continued 
interest not only as antioxidants, but also because of their bioactive properties in vivo 
(Sreeram et al., 2006; Sreeram, 2008). Berries of Vaccinium species are especially known for 
their antioxidant activities and have been extensively studied. The protective effects of berries 
have been attributed to their phenolic content which further determines its antioxidant 
capacity. Antioxidant potential of a compound can be defined as the potential to suppress 
the effect of free radicals or ROS that are responsible for causing oxidative damage to cells. 
Several mechanisms by which antioxidant compounds suppress oxidative stress are: 1) By 
scavenging free radicals, 2) by metal chelation 3) by breaking the chain reaction of auto-
oxidation and 4) by a reduction mechanism (Brewer, 2011). The three commercially 
important berry crops of Vaccinium species are blueberry (Vaccinium angustifolium), 
cranberry (Vaccinium oxycoccos and Vaccinium macrocarpon) and lingonberry (Vaccinium 
vitis-idaea). Other berries of the Vaccinium species include bilberry (Vaccinium myritillus), 
red huckleberry (Vaccinium parvifolium), sparkleberry (Vaccinium  arboreum)  and  creeping  
blueberry  (Vaccinium  crassifolium).  The characteristic feature of these berries is fleshy fruit 
with high ascorbate and anthocyanins levels (Yao and Vieira, 2007). It was reported that 
these fruits possess several beneficial properties such as antioxidant, anti-tumor, anti-ulcer, 
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and anti-inflammatory activity (Zafra-Stone et al., 2007). Owing to their high phenolic 
levels, berries have been shown to exhibit a wide range of biological effects such as 
anticarcinogenic effects (Knekt et al., 1997) and prevention of cardiovascular diseases 
(Hertog, 1993; Keli et al., 1996). Apart from the nutritional value, berries serve as 
protection against several other diseases and disorders by such mechanisms as cancer 
suppressive actions (Knekt et al., 1996; Mertens-Talcott et al., 2003; Olsson et al., 2004; 
Juranic et al., 2005), alleviating coronary heart disease (Hertog et al., 1993; Knekt et al., 
1996), stroke (Keli et al., 1996), and some other degenerative diseases resulting from 
oxidative stress (Ames et al. 1993). Cranberry proanthocyanidins have been shown to 
maintain urinary tract health (Foo et al., 2000a; Foo et al., 2000b; Howell et al., 2005). A 
variety of species from this family are utilised as commercially important fruit crops, and 
medicinal plants (Jaakola et al., 2001).  A plethora of literature is available about the protective 
effects of wild blueberries in animal model systems (Norton et al., 2005; Del Bo’ et al., 
2010; Kristo, et al., 2012). According to some recent reports, consumption of wild 
blueberries for six weeks significantly decreases oxidative stress which causes oxidized DNA, 
and increased resistance to damage (Riso et al., 2012). In particular, the potential of berries 
and their constituents to protect the brain from aging and neurodegenerative diseases has gained 
increased attention in recent years.  For example, dietary supplementation with polyphenol 
containing fruits can decrease age-related behavioral deficits in rats (Shukitt et al., 2005). In 
a recent study conducted with a mouse model of AD, treatment with berries rich in 
polyphenols decreased the extent of behavioral abnormalities associated with the disease 
(Vepsäläinen et al., 2012). Other experimental studies have shown that rats fed a diet 
enriched with blueberries can protect the brain against oxidative stress and associated 
learning deficits (Duffy et al., 2008). Surprisingly, a diet enriched with blueberries has been 
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demonstrated to later protect animals from the damage induced by ischemic stroke (Sweeney 
et al., 2002; Wang et al., 2005).  
         Leaves are an important part of the plants which are mostly responsible for photosynthesis. 
Several research groups have reported on the health benefits of leaves. One of the most 
common uses of leaves is in the preparation of beverage, Tea. Various studies suggest some of 
the health benefits of both green and black teas in cardiovascular, anti-diabetic, cancer and anti-
aging effects (Khan and Mukhtar, 2013). Leaves of Aloe vera have been traditionally used for its 
cosmetic value (Gupta and Malhotra, 2012). Ethanolic extract of Olea Europea L. leaves have 
shown antithrombotic effect in rabbits (Dub and Dugani, 2013). Leaves of Brassica Juncea are 
known to be of therapeutic importance for the cognitive disorders associated with diabetes or 
oxidative stress to the brain (Thakur et al., 2013). Another study showed the beneficial effects of 
antioxidants present in leaves and flowers of Erica australis L. (Nunes and Carvalho, 2012). 
Interestingly, results in this study showed that leaves of this plant had double the antioxidant 
activity than the flowers and the radical scavenging activity of leaves was almost three times that 
of flowers.   
Newfoundland and Labrador is rich in blueberry and lingonberry plants. These berries are well 
known to be rich in antioxidants and that made us select these plants for my study. We drew our 
interest towards leaves as well because less research has been carried out on them and some 
studies have shown their beneficial effects. We believed that leaves and berries of these plants 
would be high in polyphenolic content.  
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1.8.1 Blueberry 
 
 
                                                   (Image taken from the website free-extras.com) 
 
Blueberries are flowering plants belonging to the genus Vaccinium. These plants have dark-
purple berries which contain high amounts of phenolic compounds, including 
anthocyanins, chlorogenic acids, flavonols, and procyanidins, which result in high 
antioxidant activity and provide health benefits (Cho et al., 2004; Huang et al., 2012). The 
anthocyanins from blueberries are considered to be nature’s most potent antioxidants and 
have demonstrated properties that extend well beyond suppressing free radicals (Srivastava 
et al., 2007). Consumption of blueberries helps in maintaining healthy blood flow via 
several mechanisms including normal platelet aggregation, healthy low-density lipoprotein 
(LDL) oxidation, and maintenance of endothelial function (Kalt et al., 2008; Shaughnessy 
et al., 2009). Blueberries are very famous in North America for their nutritional and 
medicinal value (Kalt and Dufour, 1997). Wild blueberries showed protection against 
cardiovascular disorders in various animal models (Norton et al., 2005; Kalea et al., 2009; 
Del Bo' et al., 2010; Kristo et al., 2010). Age-related motor and cognitive decrements in 
rats could be reversed by using lowbush blueberries (Joseph et al., 1999). A diet containing 
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blueberry extracts also showed reduction in plaque formation in the case of an AD animal 
model (Joseph et al., 2003). The above studies have shown the positive health effects of 
blueberry fruits in humans and in in vitro models. There is much less information about the 
beneficial effects of blueberry leaves. Crude phenolic extracts of blueberry leaves were found 
to have shown antioxidant activity in a β-carotene linoleate model system and the radical 
scavenging effect was found to be very high as well (Naczk et al., 2003). Some studies have 
also shown beneficial effects against diabetes (Cignarella et al., 1996) and fatty liver disorders 
(Yuji et al., 2013). Lingonberry plants were the second variety of berry I was interested in.  
 
 
 
 
1.8.2 Lingonberry 
 
                                 
                                    (Image taken from the website www.naturephoto-cz.com) 
        
 
      
  
 
Lingonberry (also known as partridgeberry) that grows natively in Newfoundland and 
Labrador, Canada is a low shrub, bearing bright red fruits. Various studies show that they have 
higher antioxidant activity when compared to other berry fruits such as blackberry, blueberry, 
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raspberry and strawberry (Wang et al., 2000, Zheng et al., 2003). Lingonberry has been used as 
a medicinal plant and there are several reports on its health benefits. Lingonberry plants are a 
very rich source of antioxidants especially phenolic compounds. Lingonberries have shown 
potential antimicrobial effects and have also shown beneficial effects against urinary tract 
infection pertaining to its high arbutin levels (Larsson et al., 1993; Ho et al., 2001). Reports 
have shown that lingonberry exhibits anticancer activity and that its extract can potentially 
induce apoptosis of human leukemia HL-60 cells (Bomser et al., 1996; Wang et al., 2005). 
Gonorrhoea, a sexually transmitted disease, has been treated by lingonberry (Duke and Ayensu, 
1985). Lingonberry helps in curing gastric diseases and lowering cholesterol levels (Dierking 
and Beerenobst, 1993). A study done on women showed that lingonberry juice has a protective 
effect against recurrent urinary tract infections (Kontiokari et al., 2001). A recent study reveals 
the protective effects of anthocyanins from lingonberry against damage caused by radiation 
(Fan et al., 2012). Leaves of lingonberry have diuretic effects and have also shown astringent 
properties (Chiej, 1984). Similar to blueberry leaves, much less information about the 
beneficial effects of lingonberry leaves using animal models is available in literature.  
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1.9 Hypotheses and Objectives of the Study 
 
 
In summary, diet is one of the most important determining factors for the health of an 
individual. A diet rich in antioxidants is considered to be good for the brain. Berries, 
especially blueberries and lingonberries, are rich in antioxidants. Berries are highly rich in 
phenolic compounds, flavanoids and vitamin C. According to the literature, it is believed 
that antioxidants help prevent and repair the stress condition that has developed due to 
oxidation, a natural process that occurs during normal cell function in the brain. Few 
cells become damaged during oxidation and the oxygen and nitrogen molecules are 
converted into free radicals, which can start a series of chain reactions to harm more cells. 
Antioxidants have the potential to reduce this overproduction of free radicals. Thus, loss of the 
reactive species or free radicals has a tendency to reduce brain aging, counteract 
neurodegenerative diseases, and improve the health of the brain. Uncontrolled activity of free 
radicals can result in oxidative stress,  which can further aggravate disease conditions like 
AD, and PD, and disorders such as TBI and stroke.  
      I believe that our berry and leaf extract samples are rich in polyphenols, anthocyanins, 
flavonoids, and tannins. I also suspect high levels of antioxidant capacities in our extract 
samples. I wanted to test the effects of these extracts in systems of neurological disorders like 
TBI and glutamate excitotoxicity in the brain, which involve oxidative stress. My hypotheses 
are: 
(1) Berry extracts exert neuroprotective effects against glutamate excitotoxicity and 
(2) Berry extracts decrease the levels of glutamate induced up-regulation of alpha-synuclein in 
rat brain cultures. 
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The major objectives of the study are: 
• To carry out extractions of the berry and leaf samples, perform biochemical analysis 
and compare the total antioxidant capacity of blueberry and lingonberry fruits and leaves. 
• To determine the biological (neuroprotective) effects of blueberry and lingonberry 
fruits and leaves in rat brain cultures, using a model of glutamate excitotoxicity. 
• To obtain preliminary data and examine the effects of different berry extracts on neurons 
which have up-regulated alpha-synuclein as a result of glutamate treatment. 
The minor objectives of the study are:  
• To determine the effect of the NMDA receptor blocker, AP5, against glutamate 
excitotoxicity because I suspect that one mechanism through which berry extracts inhibit 
cell death is by blocking the NMDA receptor induced excessive intracellular Ca
2+
. 
• To test the effect of blueberry fruit extract in a TBI model (94A cell injury controller) in rat 
brain cultures. 
• To perform lactate measurements for different samples in order to get an additional 
estimation about the altered health of the cells. 
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CHAPTER 2 
METHODS 
 
 
 
2.1 Extract Preparation 
 
Plant materials used in the present study are fruits and leaves of wild low bush 
blueberry (Vaccinium angustifolium Aiton) and lingonberry (Vaccinium vitis idaea). 
Blueberry samples were collected near Fort Amherst, St. John’s, NL, Canada in September 
2011. Lingonberry samples were collected at Bauline, St. John’s, NL, Canada in October 
2011. Samples were harvested and stored at -20 ºC within an hour of collection. Fruit and 
leaf samples of each kind were divided into three sections before extraction. Sample extraction 
of each section was carried out from the collected leaf and fruit samples on different days in 
80% (v/v) acetone with 0.2% formic acid in the ratio 1:2 and was subjected to 30 min 
shaking on ice. This extraction procedure was used because acetone and formic acid were 
previously found to be the best extraction solvents among ethanol, methanol and acetonitrile 
at various aqueous mixtures with different shaking periods (Vyas et al, 2013). The sample 
mixture was then centrifuged at 20,000 g for 20 min at 4ºC. Supernatants were collected and 
the procedure was repeated with the residue. Both the supernatants were mixed together 
and the final concentrations for leaf and fruit samples were 25 mg/ml and 250 mg/ml of 
fresh weight respectively. So, based on the extraction day, fruit and leaf samples were divided 
and termed as “n”. The “n” value for our fruit and leaf extraction and assays was three (n=3). 
The cell culture experiments were carried out after the samples were filtered through a 
sterile filter of 40 m pore size. 
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2.2 Biochemical assays 
 
Blueberry and Lingonberry leaf and fruit extracts were further diluted ten times for 
biochemical assays. 
 
2.2.1 Determination of total soluble phenolics 
 
Total soluble phenolic content in both leaves and fruits was determined using Folin-
Ciocalteu reagent as described by Chandrasekara and Shahidi (2011) with some 
modifications. 0.5 ml of Folin-Ciocalteu reagent was added to centrifuge tubes containing 
0.5 ml of extracts and vortexed. One ml of saturated sodium carbonate solution was added to 
each tube to neutralize the reaction. The final volume was adjusted to 10 ml by water and 
vortexed for 30 sec. The reaction mixtures were kept in the dark for 35 min at room 
temperature and then centrifuged at 4,000 g for 10 min. The absorbance was measured at 725 
nm. The total soluble phenolic content of each sample was determined using gallic acid 
standard curve and expressed as milligrams of gallic acid equivalents (GAE) per g of berry or 
leaf fresh weight. 
 
2.2.2 Determination of total anthocyanin content 
 
Total anthocyanin content of samples was measured by the pH differential method described 
by Foley and Debnath (2007). KCl and sodium acetate buffers were prepared at pH 1.0 and 
4.5 respectively. One ml of extract was added to four ml of KCl. In the same way, one ml 
of extract was added to four ml of sodium acetate. These mixtures were kept in dark for 15 
min at room temperature. Absorption at 510 nm and 700 nm was measured in buffers at pH 
1.0 and pH 4.5 and the difference between the two values was used to determine total 
anthocyanin content. Results are expressed as GAE. 
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2.2.3 Determination of total flavonoid content 
 
Total flavonoid content was measured by the aluminum chloride colorimetric assay (Zhishen 
et al., 1999). One ml of extract or standard solution of catechin (0.5 mg/ml) was mixed with 4 
ml of water, followed by addition of 0.3 ml 5% NaNO2, of 0.3 ml of 10% AlCl3 (after 5 min) 
and 2 ml of 1 M NaOH (one minute later), the volume was adjusted (with water) to 10 ml. The 
absorbance was measured at 510 nm. Total flavonoid content was expressed as μmol of 
catechin equivalent (CE) per g of leaf or fruit. 
 
2.2.4 Determination of total proanthocyanidin (tannin) content 
Proanthocyanidin contents of extract samples were determined by the method developed by 
Chandrasekara and Shahidi (2011). Five ml of 0.5% vanillin-HCl reagent were added to 1 ml of 
extract, mixed thoroughly and incubated at room temperature for 20 min. A separate bank for 
each sample was read with 4% HCl in methanol. The absorbance was read at 500nm, and the 
content of proanthocyanidins was expressed as µmol of catechin equivalent (CE) per g of leaf 
or fruit. 
 
2.2.5 Determination of total Antioxidant activity 
Total antioxidant capacity of samples was determined by the 2, 2-diphenyl-1-picrylhydrazyl 
(DPPH) assay which was conducted according to the method of Brand-Williams et al (1995) 
with some modifications. The stock solution of 1 mM DPPH in methanol was diluted to 60 
µmol, 1.9 ml of the latter was mixed with 0.1 ml leaf extract, shaken vigorously and left in the 
dark for 20 mins. The absorbance was read at 515 nm. The scavenging capacity was expressed 
as % of inhibition of DPPH consumption. The Gallic acid standard curve was used to express 
the results as GAE. 
 
 
27  
 
2.2.6 Determination of reducing power 
The reducing power of extracts was determined by the method described by Chandrasekara and 
Shahidi (2011). The medium of the assay was 200 mM phosphate buffer (pH 6.6) with 1% 
potassium ferricyanide. 2.5 ml of diluted extract was added to the assay buffer and incubated 
for 20 min at 50ºC and then 2.5 ml of 10% trichloroacetic acid (TCA) was added to the assay, 
mixed and then centrifuged for 10 min at 1750 g. 2.5 ml of supernatant was transferred to 
empty tubes and combined with 2.5 ml of de-ionized water and 0.5 ml of 0.1% FeCl3. The 
absorbance was measured at 700 nm, and the results were expressed as ascorbic acid 
equivalents using appropriate standard curves. 
 
 
2.3 Cell culture Experiments 
 
 
2.3.1 Poly-L-ornithine plate coating 
Poly-L-Ornithine (PLO-500 μg/mL; Sigma) promotes the adhesion of cells to culture wells. 
To prepare the PLO solution, 100 mg of PLO was mixed with 10 ml of distilled water to 
achieve a 10 mg/ml solution. 300 µl of this solution was then aliquotted to centrifuge tubes (2 
ml) and then these were stored at -80ºC. The PLO coating solution was made by mixing 6 ml 
of distilled water with 1 aliquot (300 µl) of PLO for each plate. In the case of Costar 24 
well polystyrene plates (Corning, NY, USA), 250 µl of PLO coating solution was then added 
to each well, and for injury plates, 1 ml of PLO coating solution was added to each well. Both 
culture plates were coated with PLO solution 1 day prior to the cell culture preparation and 
plates were incubated in a humidified incubator at 37 ºC with 5% CO2. 
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2.3.2 Solution preparation for Dissection 
 
 
2.3.2.1 Hank’s buffered salt solution 
 
Hank’s buffered salt solution (HBSS) is without calcium chloride, magnesium chloride 
and magnesium sulphate. HBSS is a solution which helps in maintaining pH and osmotic 
balance. It also provides the cells in the culture with organic ions and required water 
content. Five ml of Penstrep (Pencillin-streptomycin an antibiotic−antimycotic solution at a 
final concentration of 100 units/mL penicillin G, 100 μg/mL streptomycin sulfate, and 
250 ng/mL amphotericin B) (Sigma, St. Louis, MO, USA), was added to 500 ml of HBSS to 
decrease the chances of bacterial or fungal contamination. 
 
 
2.3.2.2 Trypsin-EDTA 0.1% 
 
Trypsin (an enzyme used for protein hydrolysis)-Ethylene diamine tetra-acetate- 
complexing/chelating agent (EDTA) is a reagent or solution, which is used to digest the 
divalent cations from the culture and help in detachment of the cells. EDTA alone does this 
but combination with Trypsin gives much better results. Trypsin-EDTA was dissolved in 
HBSS containing Penstrep to obtain 10 µg/ml. 100 ml of Trypsin-EDTA was added to 100 
ml of HBSS containing 1 ml of Penstrep to make a solution of 10µg/ml and stored in -18ºC. 
 
 
2.3.2.3 Growth Media Preparation 
First, growth media free of horse serum was prepared by adding 5 ml of sterile PenStrep 
solution, 8 ml glucose solution (Sigma), 5 ml sodium pyruvate solution (GIBCO), and 5 ml of 
N2 supplement (GIBCO) into a 500 ml bottle of sterile Basal Medium Eagles (BME) (GIBCO, 
Grand Island, NY, USA) and was stored at 4 ºC. Then, to make growth media containing 10% 
HS (GIBCO), 4.5 ml HS was added to 45 ml growth media in a 50 ml labeled Falcon tube, 
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which was stored at 4ºC. The solution was sterile-filtered prior to use. 
 
 
2.3.2.3.1 Solutions for Growth media preparation 
 
Glucose solution - 32.5 gm of D (+/-) Glucose was dissolved in 67.5 ml of distilled water 
and stored at 4ºC. 
Sodium pyruvate solution - 550 mg of sodium pyruvate was mixed with 50 ml of Distilled 
water and stored at 4ºC. 
 
2.3.2.4 Culture media Preparation 
Serum free culture media was prepared using BME (500 ml- GIBCO) containing 5 ml of 
PenStrep solution, 8 ml glucose solution (Sigma), 5 ml sodium pyruvate solution (GIBCO), 5 
ml of N2 supplement (GIBCO) and 10 ml of B27 (GIBCO) supplements. N2 and B27 
supplements are preferably added at the end. Medium was then sterilized through a bottle filter 
and stored at 4ºC. 
 
2.3.3 Dissection 
The brains of 1-3 day old rat pups, supplied by Animal Care Services, were dissected and 
cultures were prepared as described below. The dissection protocol was approved by the 
Institutional Animal Care Committee of Memorial University (protocol 12-20-JW). The 
centrifuge was switched on an hour prior to the start of the dissection in order for it to cool to 
4ºC. The rat pups were euthanized and brains were removed from the skull and placed in 15 ml 
cold HBSS solution supplemented with 10 mg/ml PenStrep in a small petri dish, which was put 
on ice. The cerebellum was cut and discarded. The right and left cortical hemispheres were 
separated by a scalpel. Then the corpus callosum, the blood vessels, and membranes surrounding 
the brain were removed under microscopic light. The hemispheres free of blood vessels were 
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then placed in a centrifuge tube containing 10 ml of cold HBSS. Before centrifuging the cell 
aggregates were dissociated to smaller pieces by gently using a serological pipette (10 
triturations). The tissue was then washed (centrifuged) at 1000 rpm at 4ºC for 3 min and the 
supernatant removed and 10 ml of fresh HBSS was added. The tissue was again washed at 1000 
rpm at 4 ºC for 3 min, and the supernatant was discarded. At this point, 0.8 ml of 0.25% 
Trypsin-EDTA in HBSS supplemented with 9.2 ml of fresh HBSS was added. This tube was 
incubated for 15 min at 37ºC. After incubation, the tube was centrifuged at 1000 rpm at 4ºC 
for 3 min. Again the supernatant was discarded and 10 ml fresh growth media was added to 
it. This tube was now centrifuged at 1200 rpm at 4ºC for 5 min. The tube was taken out of the 
centrifuge and supernatant was discarded. Four ml of fresh growth media was added and cells 
were triturated using a 5 ml serological pipette until all large aggregates were dissociated. It 
was further triturated with the same pipette equipped with a 100 µL plastic pipette tip. Now 
the suspension was filtered through a 70 µm nylon strainer into a 50 ml plastic tube. The 
suspension was diluted with growth media up to 12 ml if using two 24 well plates. The PLO 
coated plates were then removed from the incubator. The PLO was removed and the wells 
were washed twice with distilled water (1 ml for injury plate and 300 µL for a 24 well plate). 
One ml of the suspension was transferred to each well (injury plate) or 250 µL was transferred 
to each well in a 24 well plate. The cultures were then stored in a humidified incubator (37ºC, 
5% CO2). Cells were grown for 9-16 days in vitro (DIV) for the experiments. Media was 
changed regularly twice a week with culture media. 
 
2.3.4 Cell Treatments 
 
Cells which were between 9 to 16 DIV were used for treatments. The cells were treated 
with different conditions as described below. 
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2.3.4.1 Solution Preparation and treatment 
 
 
2.3.4.1.1 Glutamate solution (100 µM final concentration) 
 
14.7 mg of glutamic acid was dissolved in 10 ml of distilled water. 30 µl of this solution 
was added to 300 µl of culture media in the cell culture wells to give a final concentration of 
100 µM. Glutamate was dissolved in sterile distilled water (dH2O). Cell cultures were 
exposed to glutamate (100 µM) in a volume of 3 µl per 0.3 ml of cell culture media, and 
control cultures received an equivalent volume of sterile dH2O. 
 
2.3.4.1.2  Solvent (acetone+ 0.2% of formic acid) 
 
We first tested whether the solvent used in the extraction of blueberry and lingonberry fruits 
and leaves had any effect on cell cultures before treating cells with the extract itself, and 
determined the appropriate amount of solvent that did not affect the cultures. Cell cultures 
were exposed to 1 µl of the solvent per 0.3 ml of culture media. 
 
 
2.3.4.1.3  Berry Extracts 
 
The cell culture experiments were carried out after the samples of extracts were filtered 
through a sterile filter of 40 µm pore size. Cell cultures were treated with 1 µl lingonberry 
and blueberry fruit extracts (250 mg/ml) and leaf extract (25 mg/ml) at the time of 
glutamate exposure, and were treated with the leaf and fruit extracts for 24 hr. We found that 
cultures treated with 1 µl of solvent alone had no significant change in cell number after 24 
hr. For each treatment plate, at least two control treatments were performed using dH2O as 
well as two glutamate treatments. Experiments were performed in at least three separate 
culture preparations and each condition was represented by at least six samples. 
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2.3.5 Dose Response 
 
Different glutamate solutions were prepared and the cultures were treated with three 
different concentrations, which were 10 µM, 100 µM and 1 mM. Glutamate was dissolved 
in dH2O. Cell cultures received glutamate solution and the control wells received an 
equivalent amount of dH2O. For achieving a concentration of 10 µM, a stock solution of 1 
mM (1.97 mg of glutamate in 10 ml of dH2O) was made. 3 µl of this solution was added to 
0.3 ml of the media. For achieving a concentration of 100 µM and 1 mM, a stock solution 
of 10 mM (19.71 mg of glutamate in 10 ml of dH2O) was made. 3 µl and 30 µl of this stock 
solution was added to 0.3 ml of media to get 100 µM and 1 mM concentration respectively. 
The treatment was for 24 hours which was followed by staining. 
 
 
2.3.6 APV Experiments 
 
AP5 or APV ((2R)-amino-5-phosphonovaleric acid; (2R)-amino-5-phosphonopentanoate) 
(TOCRIS) is a selective NMDA receptor antagonist that competitively binds to the ligand 
binding site on the receptor and inhibits the action of ligand (glutamate). Two different 
concentrations of APV – 30 µM and 100 µM were selected based on the literature and a 
common stock solution was made. A stock solution of 1 mM was made by adding 1.97 mg of 
D-APV to 10 ml of distilled water. To achieve a concentration of 30 µM in the media, 9 µl 
of APV was added to 291 µl of culture media. Another concentration of 100 µM was 
achieved by mixing 30 µl of APV with 270 µl of culture media. Addition of APV solutions 
alone was performed to see if APV had any effect on the cells. In normal conditions, these 
two different concentrations of APV were mixed with 100 µM glutamate and added to the 
media. In the case of 30 µM APV, 3 µl of 1 mM glutamate and 9 µl of APV was added to 
288 µl of culture media. In the case of 100 µM APV, 3 µl of 1 mM glutamate and 30 µl 
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of APV was added to 267 µl of culture media. The treatment was for 24 hours and then it 
was followed by the staining protocol. 
 
 
2.3.7 In vitro traumatic injury 
In a set of experiments we used a model 94A Cell Injury Controller developed by Ellis et al. 
(1995) (Bioengineering Facility, Virginia Commonwealth University, Richmond, VA, USA) 
for injuring the cells. For this set of experiments, the cell cultures were grown on 
deformable Silastic membranes in 6-well FlexPlates. For treatment, after addition of fresh 
300 µl of fresh culture media, a 50 ms pulse of compressed air is delivered to the wells, 
which deforms the Silastic membrane and adherent cells to varying degrees controlled by 
pulse pressure as shown in Fig 2.1. The extent of cell injury is dependent on the degree of 
deformation, or stretch (Ellis et al, 1995). This is followed by the staining technique 24 
hours later. 
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Fig 2.1 Cell injury controller 
 
Cell cultures are grown on deformable Silastic membranes in 6-well FlexPlates. A 50 ms 
pulse of compressed air is delivered to the wells, which deforms the Silastic membrane 
and adherent cells to varying degrees controlled by pulse pressure. The extent of cell 
injury is dependent on the degree of deformation, or stretch (Ellis et al., 1995). 
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2.3.8 Staining, Fixing and Imaging of cell cultures 
 
After 24 hrs of cell treatment (control, 100 µM glutamate, 100 µM glutamate with berry 
extracts, injury, injury with berry extracts), 250 µl of culture media was removed from each 
treated well in case of 24-well plate. Then 250 µl of propidium iodide (PI) solution was 
added to each well in the dark. After 5 mins, PI was removed and wells were washed with 
PBS pH 7.4. 4% Paraformaldehyde fixative solution (250 µl) was added to each well and was 
allowed to stand for 20 minutes. Wells were washed twice with PBS solution and once with 
100% ethanol to remove any excess moisture. 10 µl of 4', 6-diamidino-2-phenylindole (DAPI) 
was added and cells were then covered with cover slips. DAPI is a fluorescent stain that binds 
strongly to A-T rich regions in DNA. It is used extensively in fluorescence microscopy. DAPI 
can pass through an intact cell membrane, therefore it can be used to stain both live and fixed 
cells. PI can only pass through damaged cell membrane. Therefore, DAPI stain gives us the total 
count of cells in the images taken and PI on the other hand indicates dying or damaged cells 
only. Images were captured using a Zeiss Observer A1 microscope and a Pixelfly qe CCD 
camera (pco, Kelheim, Germany). Five random images per well were taken using different 
filters and a magnification of 200x. These images were then counted manually. Images of 
DAPI positive cells were captured with a DAPI optical filter set. At least two investigators 
who were blind to the treatment conditions counted the amount of cells in each image. Each 
well on a given day is considered to be “n”, which consist of the average counts of five captured 
images. The mean value of both the readings for each well was generated and calculated 
accordingly. Data on the number of DAPI- positive cells is expressed as % of control values 
for each given experimental day. Condensed nuclei data is expressed as the % of the total 
amount of DAPI-positive cells that contained condensed nuclei within each condition. The 
% of condensed nuclei was calculated using the program Image J (Rasband et al., 1997). 
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Representative images of cellular morphology in control and glutamate-treated cultures were 
also captured using differential interference contrast microscopy. 
 
 
2.3.8.1  Preparation of Propidium iodide solution 
 
Propidium iodide solution was made by diluting 3 µl of propidium iodide in 10 ml of 
PBS solution in the dark. 
 
 
2.3.8.2  Preparation of Paraformaldehyde Fixative 
 
400 ml of distilled water was taken in a 1000 ml beaker under a fume hood and was heated 
to 70ºC and then 40 g paraformaldehyde (PFA) was added and the solution was stirred 
well, as the solution appeared cloudy. Cold 10 N NaOH was added slowly drop wise to the 
solution until it cleared. 500 ml of 0.2 M cold Phosphate buffer was added to it. Then distilled 
water was added to the solution to bring the final volume up to 1000 ml making it 4% PFA 
concentration. This solution was filtered using a bottle filter and stored at 4ºC. 
 
 
2.3.9 Alpha-Synuclein Experiments: Staining and Imaging 
 
After 24 hrs of cell treatment, 250 µl of culture media was removed from each treated well 
in the case of 24-well plates. All wells were washed twice with Phosphate Buffer Solution 
(PBS). 4% PFA fixative solution (250 µl) was added to each well and was allowed to stand for 
20 min. Wells were then permeabilized with 0.2% Triton X for 10 min. This was 
followed by washing once with PBS solution. Blocking solution was added to incubate 
the cultures for 30 min. After removal of this solution, cultures were incubated with 
primary antibodies to microtubule-associated protein-2 (MAP-2) and alpha-synuclein in 
10% blocking solution diluted in PBS for 1 hour. The cultures were again washed twice 
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with PBS. Cultures were then incubated with secondary antibodies such as Alexa 488 and 
Alexa 595 in 10% blocking solution diluted in PBS for 1 hour. The wells were again washed 
with PBS twice. Cultures were at last washed with 70% and 100% ethanol to remove any 
excess moisture. After the cultures dried, 10 µl of DAPI was added and cells were then 
covered with cover slips. Images were captured using a Zeiss Observer A1 microscope and 
a Pixelfly qe CCD camera (pco, Kelheim, Germany). Five random images per well were 
taken using different filters and a magnification of 200x. These images were then counted 
manually. Images of DAPI positive cells were captured with a DAPI optical filter set. 
 
 
2.3.10  Lactate Measurements 
 
Lactate measurements were also performed in media from cortical cultures. Cultures received 
a complete media change just before glutamate treatment and treatment in the presence of 
extracts, and samples of media were removed from cultures 24 hours after glutamate exposure 
and stored at −20°C until measurements. Lactate concentrations in media were determined 
electrochemically with a biochemical analyzer (Analox Instruments, Ltd, UK). Data are 
presented as mmol/l. All experiments were completed using three separate culture 
preparations between 9 and 16 DIV. 
 
 
 
2.4   Statistical analysis 
 
All of the biochemical experiments were repeated at least three times. Data in the text and 
the figures are expressed as means ±SE of three replicates. Statistically significant differences 
were determined by the non-parametric unpaired t-test using the statistical program SPSS 
(IBM Inc.). In all cases the confidence coefficient was set at 0.05. The data for the bioactivity 
(cell culture) experiments were analyzed with one-way ANOVA (p < 0.05) followed by 
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Tukey’s multiple comparisons test using the statistical program GraphPad Prism (La Jolla, 
CA, USA). Data represented in figures are expressed as means ± SE of at least 6 wells per 
condition. Significance was also set at p < 0.05 for these experiments. 
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CHAPTER 3 
RESULTS 
 
A portion of the results described here have been published in the article named “Chemical 
analysis and effect of blueberry and lingonberry fruits and leaves against glutamate-mediated 
excitotoxicity” from the Journal of Agriculture and Food Chemistry. The list of authors are 
Vyas, P., Kalidindi, S., Chibrikova, L., Igamberdiev, A. U., & Weber, J. T. (2013) where Vyas 
P. and Kalidindi S. have contributed equally. 
 
 
3.1 Biochemical assays 
 
 
The content of total soluble phenolics, flavonoids, anthocyanins and tannins was found to 
be significantly higher in lingonberry fruits as compared to blueberry fruits (Fig. 3.1). This 
same trend was observed for leaves except for flavonoid content, in which the leaves of 
blueberry had a higher content as compared to those of lingonberry. The content of total 
soluble phenolics, flavonoids, anthocyanins and tannins was significantly higher in the leaves 
of both species versus the fruits (p<0.05). This latter finding correlated well with total radical 
scavenging capacity and reducing power, in which the leaves had much higher activity 
compared to fruits (Fig. 3.2). The reducing power of the leaves of both plants was similar, but 
the radical scavenging capacity was significantly higher in lingonberry leaves versus 
blueberry leaves (p<0.05). There was no significant difference between the blueberry and 
lingonberry fruits in scavenging activity and reducing power.  
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Fig 3.1 Total phenolic, anthocyanin, flavonoid and tannin content in extracts. Total 
phenolic, anthocyanin, flavonoid and tannin content in wild blueberry and lingonberry extracts 
from fruits and leaves found in Newfoundland. Data is expressed as the mean ± SE. n=3 for 
each experiment. “n” value represents the sample extracted on a particular day. *-indicates values 
differ significantly from blueberry data at p<0.05 (non-parametric unpaired t-test). The content 
of total soluble phenolics, flavonoids, anthocyanins and tannins was significantly higher in the 
leaves of both species versus the respective fruits. GAE: Gallic acid equivalents; CE: catechin 
equivalents. (In Vyas, Kalidindi, Chibrikova, Igamberdiev and Weber, 2013)
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Fig 3.2 Total radical scavenging activity and reducing power. Total radical scavenging 
activity and reducing power in blueberry and lingonberry extracts from fruits and leaves. Data is 
expressed as the mean ± SE. n=3 for each experiment. “n” value represents the sample 
extracted on a particular day. *-indicates values differ significantly from blueberry data at 
p<0.05 (non-parametric unpaired t-test). GAE: Gallic acid equivalents; AsA: ascorbic acid 
equivalents. (In Vyas, Kalidindi, Chibrikova, Igamberdiev and Weber, 2013)
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3.2 Cell culture experiments 
 
In preliminary studies I found that treatment of cultures with 1 µl of solvent alone had no 
significant change in cell number after 24 hours and 10 M glutamate produced a cell loss of 
17.0 5.7 %, which was not statistically significant. 1 mM glutamate treatment did not 
cause much cell death (Fig 3.3). However, 100 M glutamate treatment for 24 hours caused 
a significant loss of cells of 23.1 5.1 %, therefore I used a concentration of 100 M 
glutamate for the remaining experiments. Analysis of cultures using light microscopy indicated 
that the cells in control (untreated) cultures had intact cell bodies and that cells consistent with 
neuronal morphology also displayed intact, smooth neurites (Fig. 3.4) indicating healthy 
cells. After treatment with glutamate for 24 hours, many cells had disrupted cell bodies, and 
there was an increase in dark punctae, which may be indicative of condensed nuclei in dead 
or dying cells (Chen et al., 2000).  
          I stained a set of cultures with PI and DAPI. PI is a fluorescent dye which stains both 
RNA and DNA. Representative images of PI and DAPI were taken under various conditions 
(Fig 3.5). PI staining indicates cell death or damaged cells. I did not quantify the PI data 
because of a condition called “co-localization” which means dual staining. Nucleolar organizer 
regions, telomeres and centromeric regions have high affinity for PI whereas other 
chromosomal regions have high affinity for both PI and DAPI. When both PI and DAPI stains 
are added to the cultures we observe a unique differential staining pattern along the 
chromosomes producing a purplish color (Fig 3.6). I believed that this purple color on the 
cells would alter our counts and the data might not be accurate.  
         Therefore, I quantified the potential neuroprotective effects of the berry extracts by 
counting the amount of DAPI-stained cells that were present in cultures under various 
conditions (e.g. Figs. 3.3, 3.7 and 3.8). Treatment with glutamate appeared to increase the 
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amount of brighter, condensed nuclei in cultures, which is often indicative of delayed cell 
death (Weber et al., 2012) (Fig 3.7). Glutamate exposed cell cultures treated with blueberry 
and lingonberry fruit extracts showed 112.9  15.1% and 79.1 12.4 % of control values 
respectively, indicating high protection from blueberry fruit, but no protection from 
lingonberry fruit (Fig 3.8). Cultures treated with leaf extracts of blueberry and lingonberry 
showed 101.8 ± 5.1% and 106.9  8.6 % of control values respectively, which was 
significantly different versus glutamate treatment alone, indicating a highly protective effect 
of the leaf extracts from both species (Fig 3.8). I quantified the percentage of cells 
displaying condensed nuclei in the same cultures in which we determined the extent of cell 
loss. Glutamate caused a trend towards an increase in the amount of condensed nuclei after 24 
hr of exposure, but this trend was not statistically significant. Interestingly, there also 
appeared to be a trend towards increase in condensed nuclei in cultures treated with 
blueberry or lingonberry leaf extract, but again these findings were not statistically 
significant.  
         I next used a selective NMDA receptor blocker (APV) instead of the berry extracts to 
determine if one possible mechanism of action of the berry extracts is by inhibiting Na
+ 
and 
Ca
2+ 
entry through this receptor type.  Two different doses of APV were selected based on the 
literature search. We quantified the % of cortical cells in different conditions (control, 100 µM 
glutamate, 30 µM APV, 100 µM APV, 30 µM APV + glutamate and 100 µM APV + 
glutamate) and tried to compare them. 100 µM glutamate as expected caused significant cell 
death. Other treatments did cause some cell death but none of this was significant (Fig 3.9). I 
could not give a firm conclusion about the mechanism of action at this point but NMDA 
receptor blockade might be one of many possible mechanisms by which berry extracts 
provide protection. 
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          Another set of experiments were performed using the 94A controller injury model 
which caused stretch to the cells. I quantified the % of cortical cells which were injured and 
compared them with the control cells as well as with injured cells in presence of blueberry 
fruit extract. Injured cells showed 31.7 7.7 % of the control cells, whereas the injured cells 
in the presence of the blueberry fruit extract showed 109.4  15.2 % of control cells which 
was significant (Fig 3.10). This suggested a high protective effect of blueberry fruit against 
traumatic injury in rat brain cultures.   
         The measurement  of  lactate  from  the  cultures  would  give  an  estimate  of  the  
metabolic changes and health of the cells. Lactate was measured in culture media 24 hours 
after treatment with 100 µM glutamate and glutamate in the presence of various extracts, 
which was then compared with the lactate in the control cells. The lactate levels for 
glutamate treated wells showed a trend towards a decrease when compared to the control 
cells, and glutamate treatment in the presence of various fruit and leaf extracts showed a lean 
towards an increase in lactate levels, which were similar to the control levels (Fig 3.11). 
However, none of these findings were found to be statistically significant.  
         Alpha-synuclein is a protein found in neurons. This protein agglomerates to form 
insoluble fibrils which are known as Lewy bodies (Wakabayashi et al., 2007) in certain 
conditions. Cell cultures which were treated with 100 µM glutamate, glutamate in the presence 
of berry extracts, injured and injured in presence of berry extracts were stained with alpha-
synuclein antibody, MAP-2 and DAPI to examine the expression of the protein alpha-
synuclein. I observed that with injury and glutamate treated cultures, there was an increased 
expression of alpha-synuclein in the neurons (Fig 3.12). Representative images of alpha-
synuclein stained glutamate with berry treated cultures are shown (Fig 3.13).  
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Fig 3.3 Glutamate Dose Response. Dose response data for glutamate induced cell death by 
different concentrations of glutamate. Cells in culture were treated with 10 µM glutamate, 
100 µM glutamate and 1 mM glutamate alone. Staining and imaging with DAPI was carried 
out after 24 hour treatment with different concentrations of glutamate. The amount of DAPI-
positive nuclei was quantified and the data is expressed as % of control values ± SEM. n= 9-11 
(n refers to the wells on a given day). Cell loss or the amount of DAPI-positive nuclei for 
glutamate treated cells was quantified and expressed. 100 µM glutamate treatment showed 
a significant loss of cells whereas 10 µM and 1mM glutamate induced cell death was not 
significant. *P<0.05 when compared with the control. 
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Fig 3.4 Morphology of cell cultures. Light microscopic images of untreated cells (control; 
top) and cells treated with 100 µM glutamate for 24 hours (bottom). Note that cells in control 
cultures had intact cell bodies and that cells consistent with neuronal morphology displayed 
intact, smooth neurites. After treatment with glutamate for 24 hours, many cells had disrupted 
cell bodies, and there was an increase in dark punctae. Scale bar = 50 μm and applies to both 
images. Cell cultures are 12 DIV. (In Vyas, Kalidindi, Chibrikova, Igamberdiev and Weber, 
2013)
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Fig 3.5 DAPI and PI stained cortical cells. Representing images of cortical cells stained 
with both DAPI (blue) and PI (red) in (A) control conditions, (B) after 24 hour treatment 
with 100 μM glutamate and after (C) 24 hour treatment with 100 μM glutamate in the 
presence of berry extracts. The presence of PI in the cells indicates damaged cells or dying 
cells. 
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Fig 3.6 PI and DAPI Co-localization.  An image showing cortical cells stained with both 
DAPI (blue) and PI (red). The image shows a phenomenon called “co-localization” (PI and 
DAPI both stains the same cells). The cells appear purplish in color. For this reason, we were 
unable to quantify PI data with confidence. 
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Fig 3.7 DAPI staining in cell cultures. Representative images of cortical cells stained with DAPI 
(blue) in control conditions, after 24 hour treatment with 100 μM glutamate, and after 24 hour 
treatment with 100 μM glutamate in the presence of blueberry and lingonberry fruit and leaf 
extracts. Note the presence of several condensed nuclei after treatment with glutamate, which 
may be indicative of delayed cell death. Images on the right are at a magnification of 200 X, 
while images on the left have been enlarged in order to better represent nuclear morphology. 
Both scale bars = 50 μm. The scale bar in the glutamate + blueberry fruit images applies to all 
three images on the left, while the scale bar in the glutamate + lingonberry leaf image applies 
to the three images on the right. Cell cultures in images on the left are 16 DIV, while those 
on the right are 15 DIV. (In Vyas, Kalidindi, Chibrikova, Igamberdiev and Weber, 2013)
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Fig 3.8 Effects of blueberry and lingonberry fruit and leaf extracts on glutamate-mediated 
cell death. Summary of the effects of blueberry (left) and lingonberry (right) fruit and leaf 
extracts on glutamate-mediated cell death. Cells were treated with 100 μM glutamate alone or 
in the presence of extracts. Top graphs: the amount of DAPI-positive nuclei was quantified and 
data is expressed as % of control values. Data is expressed as % of control values ± SEM. n=6-
16 11 (n refers to the wells on a given day). *p<0.05 vs. control; **p<.05 vs. glutamate only 
(one-way ANOVA with Tukey’s post-hoc analysis). Bottom graphs: the percentage of 
nuclei that exhibited a condensed morphology in the same culture wells used to generate the 
data in the top graphs. (In Vyas, Kalidindi, Chibrikova, Igamberdiev and Weber, 2013)
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Fig 3.9 Effect of NMDA receptor blockade against glutamate excitotoxicity. APV is a 
selective NMDA receptor blocker. Here, a series of experiments were carried out by treating 
cells with two different concentration of APV (30 µM and 100 µM) alone and in the 
presence of glutamate. 100 µM glutamate was significant when compared to the control and 
caused a cell death of approximately 23 % of cells. Data is expressed as % of control values ± 
SEM. n=9-11 (n refers to the wells on a given day). *P<.05 when compared with control. 
 
 
52  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.10 Effect of Blueberry fruit against traumatic injury. Summary of the effects of 
blueberry fruit extracts on traumatic injury-mediated cell death. Cells were injured with a 
94A controller (injury model) alone or in the presence of extracts. The stretch (31 %) caused 
by the injury model was equivalent to 5.5 mm deformation. Data is expressed as % of control 
values ± SEM. n=4 (n refers to the wells on a given day). *P<.01 compared with both control 
and blueberry treated cells. 
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Fig 3.11 Lactate Analysis. Release of lactate in the culture media 24 hours after treatment 
with dH2O (control), 100 µM glutamate and glutamate in the presence of different extracts was 
measured. Data is expressed as % of control values ± SEM. All conditions had n=22 for control 
and n=6-14 for experimental conditions (n refers to the wells on a given day). No significance 
was observed with one-way ANOVA and Tukey’s multiple comparison test. 
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Fig 3.12 Alpha Synuclein expression in cortical cells. Representative images of rat brain 
cortical cells stained with DAPI (blue), MAP-2 (green) and alpha-synuclein (red) in control 
conditions, after 24 hour treatment with 100 μM glutamate, and after 24 hour of injury. We 
can observe the presence of alpha-synuclein in the neurons after treatment with glutamate  
and after injury compared to control conditions, which may indicate increased expression of 
the protein alpha-synuclein. The arrows point to neurons which show the presence of alpha-
synuclein in the cell bodies. Images are at a magnification of 200x and the scale bars = 50 μm. 
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Fig 3.13 Alpha Synuclein in berry treated cells in the presence of glutamate. Representative 
images of rat brain cortical cells stained with DAPI (blue), MAP-2 (green) and alpha-synuclein 
(red) 24 hours after treatment with berry extracts + glutamate. We can see the presence of alpha-
synuclein in a few neurons and glial cells (pointed to by arrows) after treatment with glutamate + 
berry extracts, which may indicate decreased expression of the protein alpha-synucelin. 
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CHAPTER 4           
DISCUSSION 
 
In this study, we collected and assayed the contents of blueberry and lingonberry fruits and 
leaves. We detected high levels of polyphenolic compounds, such as anthocyanins, 
flavonoids, and tannins, in blueberries and lingonberries (partridgeberries) growing natively in 
Newfoundland. When we compared the two fruit extracts the lingonberry extract had 
much higher anthocyanins, flavonoids, and tannins, making it much richer in polyphenolic 
content. We observed that the leaves of both species have a higher level of phenolic 
compounds compared to the respective fruits. The leaves were found to have much higher total 
antioxidant capacity than the fruits, as indicated by radical scavenging activity and 
reducing power, which confirms previous findings for lingonberry (Vyas, Debnath and 
Igamberdiev, 2013). These biochemical data are generally in line with the biological activities 
of the extracts on glutamate-exposed rat brain cultures with some alterations. For example, 
although the fruit extract of blueberries was highly protective against glutamate toxicity in 
rat brain cultures, lingonberry fruits were not protective. However, the extracts from leaves 
of both plant species were highly neuroprotective in our cell culture model. This could be 
because of the direct correlation of the involvement of ROS and RNS during glutamate 
excitotoxicity (Wang and Michaelis, 2010) and the role of polyphenols in scavenging ROS 
(Fang et al., 2002). The fruits and leaves of blueberry and lingonberry plants are rich in 
polyphenolic content and all extracts except the lingonberry fruit extract have shown protection 
against glutamate excitotoxicity. 
            Glutamate, which is a major endogenous excitatory neurotransmitter in the mammalian 
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CNS, plays an important role in long term potentiation, learning, and memory under normal 
physiological conditions (Chen et al., 2009). Glutamate also plays an important role in normal 
neurophysiology, such as those involved in a variety of cognitive functions (Rahn et al., 2012), 
and is involved with synaptic plasticity, believed to be the cellular mechanism of learning 
and memory (Kim and Linden, 2007; Lamont and Weber, 2012). The appropriate levels of 
glutamate are important as it should be present in the correct concentration in order to produce 
its normal physiological effects. However, increased glutamate levels result in glutamate-
mediated excitotoxicity, which can lead to cell damage and death (Goto et al., 2009) and 
contribute to impaired signaling and cell death (Greenwood et al., 2007). This phenomenon 
could be due to excessive glutamate release in the synapse, over-activation of glutamate 
receptors, or inadequate uptake of glutamate by glial cells through transporters. This 
pathological process can contribute to brain aging and neurodegeneration over the course of 
many years, but there is a possibility that it can occur very rapidly during severe insults 
such as those seen in stroke and TBI (Nakamura et al., 2010; Weber, 2004). Excitotoxicity 
generally causes an excessive elevation of intracellular Ca
2+ 
levels (Chen et al., 2000; Mehta 
et al., 2012), which in turn causes changes in the functioning of neurons and can over activate 
several Ca
2+ 
dependent enzymes leading to changes in regular cellular processes (Nicholls et 
al., 2004; Weber, 2004; Wojda et al., 2008). This leads to a cascade of reactions which may all 
lead to cell death. As a consequence of the activation of calcium-dependent enzymes such as 
xanthine oxidase (Atlante et al., 2000), phospholipase A2 (Wood et al., 2003; Weber, 2004) 
and nitric oxide synthase, free radicals including ROS and RNS are produced in cells 
(Mehta et al., 2012). Excitotoxicity is also responsible for oxidative dysfunction in 
mitochondria (Rego and Oliveira, 2003), which could lead to further ROS generation. Therefore, 
in our experiments when cell cultures were exposed to a high concentration of glutamate, 
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receptors were over activated, which likely led to oxidative and nitrosative stress contributing 
to cell death. However, elevated levels of Ca
2+
 can also activate other enzymes, such as 
endonucleases and proteases, which can degrade DNA and proteins, respectively (Weber, 
2004). Therefore, there is a possibility that cell death may have occurred through 
mechanisms other than oxidative and nitrosative stress, and the protective effect of our berry 
extracts may not have been due to antioxidant and/or anti-nitrosative properties. Some 
studies in cultures support antioxidant or anti-nitrosative mechanisms against glutamate 
toxicity. For example, Ahn et al. (2011) found that 100 μM glutamate causes hippocampal cell 
death by altered calcium signaling and nitrosative stress. Another recent study by Lee et al. 
(2012) showed that 100 µM glutamate caused oxidative stress by excessive release of calcium. In 
our culture system, we found that  neurons generally constitute  only ∼12%  of  the total cells,  
with  the  remaining  cells  mostly made  up  by glial cells, specifically astrocytes. After an 
exposure of 100 µM glutamate we observed a total cell loss of ∼23%. This suggests that most of 
the cell loss was due to the death of glial cells rather than the neurons. It is possible that glial 
cells died due to excessive glutamate uptake, and cell swelling, however, for example, Chen et 
al. (2000) found that oxidative stress was the primary reason for the death of astrocytes in the 
cultures. Therefore, this finding suggests that berry extracts could likely protect glia through 
antioxidant properties. Our qualitative finding of increased dark punctae and altered 
morphology in glutamate-treated cells and the presence of disrupted cell bodies is also 
consistent with the response of astrocytes exposed to glutamate toxicity (Chen et al., 2000). In 
a set of experiments we tested the effect of 10 µM and 1 mM glutamate on cell viability. 1 mM 
did not cause much cell loss while 100 µM glutamate caused maximum cell death. This decrease 
in cell death with a higher glutamate dose might be due to super-saturation of glutamate. Excess 
glutamate in culture media may have been coming out of solution and not taken up by the cells. 
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Another possible reason may be down regulation of glutamate receptors in the presence of 
excessive glutamate which causes lesser cells to be available to actively take up glutamate 
leading to a decrease in cell death. 
         Many polyphenolic compounds have antioxidant capacity and are potent free radical 
scavengers, and a plethora of literature is available on the antioxidant capacities of phenolic 
compounds (Kähkönen and Heinonen, 2003; Chandra et al., 2004; Naczk and Shahidi, 2006) 
and their protective effects (Kong et al., 2003; Rossi et al., 2003). Other groups have found 
similar findings compared to ours using nervous system cell culture models to assess 
potential neuroprotective effects of various polyphenolic compounds. For example, Ahn et 
al. (2011) found that a proanthocyanidin extract from grapes could inhibit hippocampal cell 
death by decreasing nitrosative stress. Lee et al. (2012) found that antioxidants found in acorn 
extract could inhibit calcium spikes and thus control glutamate induced excitotoxicity. Similar 
results have been found with other antioxidant compounds such as carotenoids from 
Pittosporum tobira. These carotenoids have been shown to protect rat cortical cells against 
exposure to 100 μM glutamate for 24 h (Moon et al., 2010), the same treatment protocol used 
in the current study. Another study showed that Apigenin, a flavonoid, could inhibit the 
excessive [Ca
2+
]i induced by glutamate treatment (Han et al., 2008). An extract from the 
fruit of Alpinia oxyphylla was shown to protect cortical neurons against exposure to 30 μM 
glutamate and also had an effect on condensed nuclei, similar to our findings (Yu et al., 
2003). However, in a model of glutamate toxicity in hippocampal cultures, a seed extract of 
Cassia obtusifolia provided no protection to either neurons or glia (Drever et al., 2008). 
Interestingly, nicotine also showed protective effects against glutamate induced neurototoxicity 
by inhibiting the formation of excess NO which was triggered due to excessive calcium influx 
(Kaneko et al., 1997). These studies indicate that many plant species containing antioxidants 
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offer protection against glutamate excitotoxicity in neurons.  
           It is very interesting that out of all of the four extracts only the extract from 
lingonberry fruit did not show any protection against toxicity in our model. The reason for this 
might be due to the actual chemical composition of the lingonberry fruit versus the other fruit 
and leaf extracts. Although our biochemical assay shows that lingonberry fruit had a higher 
overall polyphenolic content when compared with that of blueberry fruit, the specific 
compounds in each extract is unknown to us. It is also possible that there are some specific 
compounds present in the blueberry fruit and other leaf extracts which are absent in the 
lingonberry fruit extract and they are responsible for the protection against glutamate toxicity. 
For example, Bhuiyan et al. (2011) found that when cell cultures were exposure to 50 µM 
glutamate it killed 40% of cortical neurons. But when a specific polyphenol (cyanidin-3-
glucoside) was added, there was no protection. The same cyanindin-3-glucoside provided 
protection against oxygen glucose deprivation in primary cortical neurons (Bhuiyan et al., 
2011). Another study done by Bhuiyan et al. (2012) found that specific anthocyanins extracted 
from black soya bean seed coat did not protect against glutamate excitotoxicity in neuronal cells 
but interestingly they found that treatment of cells with 1 µM of MK801 (non-competitive 
NMDA receptor antagonist) controlled the glutamate induced cell death. It is known that not all 
compounds or polyphenols can cross the blood brain barrier (BBB). Mostly, nutrients and highly 
lipophilic compounds have a tendency to cross the endothelial layer and reach the brain. 
Previous studies have shown that some dietary polyphenols can cross the BBB, (Vouzour et 
al., 2012) and some flavonoids are specifically known to cross the BBB (Faria et al., 2011, Faria 
et al., 2014). Anthocyanins specifically have been detected in brain tissue after oral 
administration to rodents (Andres-Lacueva et al., 2005; Talavera et al., 2005; El-Mohsen et al., 
2006). Estimates of specific anthocyanins in brain tissue are generally in the subnanomolar 
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range (∼0.2−0.25 nmol/g tissue) (Talavera et al., 2005; El-Mohsen et al., 2006). Berry 
anthocyanins have also been detected to cross the BBB (Milbury and Kalt, 2010). Direct 
comparisons with the above studies may not be appropriate as we used the whole extract and not 
specific anthocyanins in the current work. There is a possibility that the specific anthocyanins in 
the whole extract are responsible for such an effect. The final concentration of the extracts we 
added was 0.833 μg/mL of fruit extract and 0.083 μg/mL of leaf extract. We have 
previously conducted chemical analysis of commercially available lingonberry extracts 
(unpublished data) and have found that these lingonberry extracts contain an estimated 63.7 
mg of cyanidin-3-galactoside/100 mg of fresh extract weight. Assuming that our fresh 
lingonberry extracts contain a similar amount of this compound, this would translate to the 
cultured cells being exposed to approximately a 10 nM concentration of fruit extract and 1 
nM in leaf extract. Talavera et al. (2005) detected a level of another cyanidin compound 
(cyanidin-3-glucoside) of 0.25 nmol equivalent/g of tissue. Therefore, the amount of extract 
that we added to cultures is likely slightly higher than what might be achieved in the brain 
after oral administration. A study was performed on the bioavailability of various polyphenolic 
compounds and the compounds which were maximally absorbed were isoflavones and gallic 
acid, followed by flavanones.  In addition, the polyphenolic compounds contained in our 
extracts may not be the predominant forms that would actually enter the brain, as a recent 
study found that although anthocyanins have a fairly high bioavailability, they undergo 
significant metabolism, producing diverse metabolites (Czank et al., 2013). A recent study has 
shown that anthocyanin and particularly its metabolites can cross the BBB and reach the CNS 
(Faria et al., 2014). Although we did not administer our extracts orally, we feel that our 
system is useful in screening specific polyphenols at various concentrations to test for 
neuroprotective potential and study the mechanisms of action of protection. The mechanism 
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of action through which the extracts caused the protection is unknown. Similarly, the actual 
mechanism for glutamate induced cell death is also not known.  
         I believe that some glutamate receptor blockers can be used to prevent the excessive influx 
of calcium into neurons via the NMDA receptors and further inhibit the cascade of reactions 
which cause cell death based on the general mechanism of action. In this case, selective NMDA 
blockers would be of much importance in accordance with the calcium entry. A previous study 
showed that NMDA antagonists such as Morphinan DX blocked glutamate induced toxicity 
(Choi et al., 1987). Another study done by Choi et al. (1988) has shown that APV in different 
concentrations provides protection against glutamate induced toxicity in cortical cultures. Choi 
et al. (1988) showed that influx of calcium through over activation of NMDA receptors was the 
major reason for cell death in cortical cultures. Therefore, we used APV, instead of the berry 
extracts, to determine the contribution of the NMDA receptor type to cell damage. Based on 
a literature review, we selected two doses of APV which were 30 µM and 100 µM. As previously 
seen, treatment of cultures with 100 µM glutamate caused a significant amount of cell death. 
Treatment of cultures with APV in the presence of glutamate gave us positive results and the 
cell death caused by 100 µM glutamate was suppressed to an extent. Treatment with only 
APV showed a trend towards cell death when compared with control levels. Unfortunately none 
of our data on NMDA receptor blockade was significant so we cannot justify that berry extracts 
provide protection against glutamate excitotoxicity solely by blocking NMDA receptors. A 
study reported that a water soluble extract from Celastrus paniculatus inhibited oxidative stress 
in rat cortical cultures produced due to glutamate by altering the function of glutamate receptors 
(Godkar et al., 2004). A recent study showed that a compound from a plant called Psoralea 
corylifolia blocked the cell death associated with retinal damage by controlling oxidative stress 
which was due to NMDA activation, calcium influx and a cascade of reactions leading to cell 
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death (Kim et al., 2013). However, NMDA receptor blockade may be one of many mechanisms 
of protection provided by the berries because as per our results APV + glutamate did suppress 
cell death to a certain level. Therefore, future studies are aimed at analyzing the threshold of 
dietary consumption of berry products and potential neuroprotection. Also, they should be 
aimed at isolating the individual compounds in the extracts and their quantification. These 
isolated compounds may be tested specifically for their protective effects against glutamate 
excitoxicity.   
          TBI is a form of damage to the brain initiated by an external force. The model used in our 
laboratory for injuring cells and mimicking the trauma created during TBI uses the 94A Cell 
Injury Controller, which creates a stretch induced trauma in mixed cultures. The stretch (31 %) 
caused by the injury model is equivalent to 5.5 mm deformation. Cell death induced by 
trauma was measured 24 hours later and cause a significant amount of cell death (more than 
60% when compared to % of control). TBI is followed by oxidative stress which worsens the 
condition. Therefore, addition of antioxidants may reduce the stress levels observed in TBI as 
seen with the neuroprotective effects of oxyresveratrol from Smilacis chinae rhizome in rat 
brain cultures (Ban et al., 2006). A study performed by Weber et al., 2012 also showed the 
potential neuroprotective effects of oxyresveratrol isolated from Morus alba L. against TBI. 
Therefore, cells were injured with the stretch injury model alone or in the presence of blueberry 
fruit extracts in order to see whether the antioxidant rich blueberry fruits are beneficial. Studies 
have previously shown the neuroprotective effects of blueberry extracts (Yang and Jiang, 2010), 
and a plethora of literature is available about blueberry fruits and their neuroprotective effects 
(Giacalone et al., 2011). Treatment of cultures with blueberry fruit extracts immediately after 
stretch injury displayed neuroprotection of cells. To our surprise, there was no cell loss and the 
number of cells was almost equal to the % control of cells when cells were stretched in the 
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presence of extracts. Although we expected our extract to cause some neuroprotection, a 
complete protection was unexpected. Future studies involving specific polyphenols isolated 
from blueberry fruits, for example cyanidin-3-glucoside and their effects against TBI might give 
us the exact mechanism of action or pathways responsible for this protective effect.  
           Lactate is a by-product of glycolysis and is a biochemical indicator of anaerobic 
metabolism. Measurement of lactate from the mixed cultures after various treatment 
conditions would give an estimate of the metabolic changes and health status of the cells 
(Choi et al., 1988). When lactate levels decreased after 24 hour glutamate treatment, we 
expected that to be an indication of alteration in the metabolic state of cells. After treatment 
with glutamate in the presence of berry extracts, we observed a slight variation in the lactate 
levels. Interestingly however, the lactate levels for the extracts + glutamate were much 
closer to the control levels when compared with that of the glutamate treatment. These 
results suggest that measurement of lactate levels in different treatment conditions could give 
us a better idea regarding the condition of the cells, but unfortunately none of this data was 
statistically significant. However, it is possible that if different time frames were used for 
measurement such as 15 minutes or 48 hours, then lactate levels may be significantly 
altered. Measurement of the lactate/pyruvate ratio and pyruvate levels specifically could give 
us a better picture regarding the metabolic changes (Weber et al., 2012). An increase in 
concentration of glutamate and the extracts might also lead to a significant change in lactate 
levels. Measurement of lactate and pyruvate levels using microdialysis and high 
performance liquid chromatography (HPLC) has been used to determine metabolic changes 
in rat brain (Hallstrom et al., 1989). Other studies have shown that lactate levels were 
used for measuring metabolic changes in ischemic conditions (Hilliered et al, 1989). 
Therefore, future studies may involve measuring lactate and pyruvate levels and their 
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ratio at different treatment time frames in order to give a better indication about cell health. 
           Alpha-synuclein is a 140 amino acid containing protein which is located mostly in 
neurons. Over expression of this protein is considered to be a hallmark for various 
neurodegenerative diseases such as PD, AD and DLB. The actual mechanism of action of this 
protein to cause neurodegeneration is not very clear (Nemani et al., 2010). We believe that 
glutamate induced excitotoxicity or injury also leads to over expression of alpha-synuclein 
which may further be a secondary factor or a link to PD. We used an alpha-synuclein antibody 
immunohistochemistry staining technique for our experiments in order to detect the presence of 
alpha-synuclein in the cultures. Cultures injured by the 94A controller or treated with glutamate 
would cause a condition like TBI or glutamate excitotoxicity, respectively, based on our 
previous experiments in the lab. As expected after antibody staining with alpha-synuclein, 
MAP-2 and DAPI, we could capture some great images which represented injured or dying cells 
with over expression of alpha-synuclein (bead formation), neurons and all cortical cells 
respectively. These images helped us believe our prediction that glutamate or injury can lead to 
an increased expression of alpha-synuclein protein (Fig 3.11), although the exact reason for this 
over expression is unknown. It is not known what happens due to this increased expression of 
alpha-synuclein in glutamate treated or injured cortical cultures. Interestingly, a study showed 
that alpha-synuclein released due to induction by valproic acid could cause neuroprotection 
against glutamate induced excitotoxicity in rat cerebellar cultures (Leng and Chuang, 2006). So 
the actual relationship between glutamate excitotoxicity and alpha-synuclein is not clearly 
understood based on our experiments and the literature. The immunostaining experimental 
technique is a qualitative way of determining alpha-synuclein. The berry extracts were used in 
the presence of glutamate to determine its effect on alpha-synuclein expression. After the 
treatment some very good images were able to be captured which showed very few neurons 
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with alpha-synuclein and most other neurons looked healthy. This might be an indication that 
berry extracts have some effect on the levels of alpha-synuclein but a definitive comment cannot 
be made at this point regarding exactly what occurs. However, an increased level of expression 
of alpha-synuclein in cortical cultures after injury or glutamate treatment is certain. Future 
studies involving other more quantitative techniques such as Western blot analysis would be a 
better way to more specifically measure increased expression of alpha-synuclein after injury or 
glutamate treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67  
CONCLUSIONS 
 
 
 
Overall, the findings suggest that consumption of blueberries and lingonberries could have a 
positive effect on the human brain. The high polyphenolic content and antioxidant capacity of 
these two species could be potentially beneficial for the prevention of disorders such as stroke 
and TBI, and I have provided further evidence that these species can be beneficial for these 
brain disorders. Studies have shown that a diet rich in fruits and vegetables, as well as 
blueberry specifically would be very healthy for the brain. An intake of a small quantity of 
blueberries daily (approximately one cup) by humans could be very beneficial for neuronal 
age deficits (Galli et al., 2002). It is possible that the consumption of fresh or frozen berries 
or a tea made from the leaves of the plants, as well as dietary supplements produced from the 
extracts of the fruits and/or leaves could slow brain aging or inhibit the development of 
neurodegenerative disorders. Therefore, ingestion of berries or supplements made from leaves 
could possibly increase the antioxidant and antinitrosative capacity of the brain. Other studies 
have shown that rats fed a diet enriched with blueberries can protect the brain against 
oxidative stress (Duffy et al., 2008) as well as stroke (Wang et al., 2000; Sweeney et al., 
2002), which suggests that the outcome from such typically debilitating disorders can be 
improved if the antioxidant levels in the brain are increased through diet. Therefore, future 
studies should involve performing detailed chemical analysis of these extracts and quantification 
of the isolated compounds to get a better idea about the individual compounds which are present 
in a high concentration. Toxicological studies specifically carried out on berry leaves could be 
very helpful as leaves were found to be very potent and are considered to be toxic in general 
when compared with the berry fruits. Lactate measurements could act as a marker for the health 
of the cells depending on the time-point of measurement. Lastly, antibody staining to alpha 
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synuclein demonstrated expression of this protein in neurons, which is associated with both 
glutamate treated and injured cells, but further experiments are needed in order to determine the 
effects of berry extracts on alpha-synuclein expression.  
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